reason report
excel increas estim pt
bottom line deliv yet anoth solid rev/ep beat
consensu rev/ep guid
lot like within perform includ anoth qtr
teen growth record itero scanner revenu y/i op
leverag bp better model sizabl ep beat full-
year revenue guidanc assum revenue clear align growth either
top upper end management lt oper goal
similar play suspect growth level like
base case drive consider upsid
plan reinvest upsid lower-than-anticip tax rate
think right move given under-penetrated
compani clear align market opportun
success dtc/market spend doubl
high roi spend similar way management guid op margin
ultim outperform start last year think
management flat y/i margin outlook prove conserv
year pt goe vs prior higher estim
impact y/i ahead consensu
saw even acceler y/i revenue growth
na clear align sale beat us/consensu
 revenue came street driven
increas utilization/expans custom base
new custom consecut qtr start beat
consensu growth across region na case start beat
consensu vs reflect increas ortho
gener practition gp channel well driven emea
season stronger apac albeit china saw slight q/q step-
season gm in-lin ebit
came project vs ep
includ tax impact ep exclud
ep vs consensu estim lp
outlook call upper-end lt growth goal
consensu management revenue outlook
y/i street in-lin us shipment
street expect upper-end
management full-year lt growth rang also consensu
scanner revenue growth track in-lin invisalign growth
project close high-end rang
well sale increas reflect slightli aggress
invisalign growth assumpt
y/i project in-lin guidanc
medic suppli devic
ep growth
impli price-to-earnings ep
price-to-earnings lt ep growth
compani inform leerink partner llc research
ep includ tax impact exclud tax impact ep would
pleas refer page import disclosur price chart analyst certif
management plan reinvest busi call flat y/
op margin expans note compani start last year
similar tone ambiti op-ex plan expect limit
margin expans despit stepped-up spend still
manag deliv op leverag sale out-performance
think potenti set similar scenario
ep guidanc consensu midpoint
base below-street op margin get mitig
tax benefit tax rate
prior forecast management expect increas invest
weight similar cadenc spend
op leverag weight back half year also
effect drive greater ep power vs ep
in-lin guidanc ep project vs
prior mostli due higher sale lower tax assumpt
us report teen case start
y/i growth reflect growth across major region
increasingli younger teens/ tween compar
management also highlight increas payoff on-going dtc marketing/
sale initi us approv mandibular advanc
import catalyst teen acceler still expect
though management expect materi contribut
us compani work process
includ collect addit data/analysi think investor
hope approv may view slight setback
otherwis fairli pristin quarter management remain confid
way increas invest direct-to-consum dtc
invisalign convers teen adult smile concierg
tv ad snapchat facebook etc educ consum
invisalign work compani implement store pilot program
nov -- predominantli aim adult case convers --
help adapt custom experi better meet need
custom plan open anoth store san jose ca
two store east coast continu believ
alloc spend dollar right area
help drive acceler adopt
rate op pt vs prior see scarciti valu
growth/profit profil mani small/mid-cap med-tech compani boast prospect
double-digit top-lin growth gm op margin expans debt cash
algn invisalign platform clear align technolog grow altern tradit
brace wire bracket expect continu experi higher util
orthodontist gener dentist practition treat malocclus patient need
tooth movement invisalign ww penetr view scratch surfac
long-term estim ww address market opportun project cc
revenu growth push broader deeper two key custom channel
orthodontist gener practition new product augment type
case invisalign address market promot doc train initi drive
higher consum demand greater doc confidence/adopt outreach aim teen
-- rel untap segment repres orthodont case
ou expans top-lin growth rate yield acceler ep growth on-going
expens leverag invest return buyback think out-year estim still leav
room upsid reflect revenu growth compound-annual-growth-rate assumpt midpoint management
competit continu forefront investor mind note eventu step-
clear align competit noth new anticip and/or denstpli
could come market clear align time-frame management acknowledg
well part continu believ differenti materi smarttrack
manufactur know-how patent protect around recent post technolog
advanc keep well posit stay lead align market continu
expand/ convert wire bracket end day view competit valid
under-penetrated categori penetr market expansionari
pt vs previous believ trade
level roughli in-lin differenti and/or monopolist technolog peer
above-averag earn power larg under-penetrated market sale acceleration/
margin expans potenti three compani univers characterist
ew trade p/e respect
average ratio current grow top bottom line slightli
faster average compani use
ep growth forecast suggest price-to-earnings appli higher
ep get us add addit cash-per-share yield
risk invest thesi price target includ sensit potenti slowdown
macroeconom environ dental industri may affect downturn vs
non-elect healthcar arena patent expir begin allow competitor
access know-how could open door better cheaper altern
diminish power monopolist posit revenu growth sustain could call
question address market invisalign smaller model invest
support growth deliv lower anticip roi limit earn power
million except ep
margin sale
scanner servic
non-gaap ep exclud impact align deferr
compani report streetaccount estim leerink partner estim
note ep includ tax impact dilut ep back item
ep would
million except ep
margin sale
scanner servic
compani report leerink partner estim
million except ep
overal revenu high
end plan invisalign revenue
volum growth high
end scanner growth in-
line invisalgin
oper profit
demand expect continu grow
sequenti na expect season
ortho
sdc expect trend continu sdc continu ramp
manufactur capac
higher expens region treatment plan
oper partial off-set higher
sequenti due continu invest go-to-
op mgn expect approx
flat result
exclud share repurchas
inc excess tax
inc excess tax
gm sale
opex sale
oper margin sale
compani report leerink partner estim
million except ep share outstand
revenu
research develop
impair goodwil
amort acquir intang asset
impair long-liv asset
income/ loss oper
interest incom expens net
net incom provis incom tax
provis incom tax
equiti loss investe net tax
ep deferr add-back
percentag sale
interest
compani report leerink partner llc estim
non-gaap ep -- ep estimate exclud revenu deferr impact addit align polici line item impact cycl estimate
dollar million except share per share data
y/i chang price
y/i chang price
y/i chang price
percentag revenu
percentag revenu geograph mix
percentag revenu product mix
servic scanner
compani report leerink partner estim
